TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
陳敏煜Chen, Min-Yu
- 協同主持人
- 執行臨床試驗年資 12 年 9 個月
-
e12013@cgmh.org.tw
發表文獻
4筆
1
Chou HH, Chen WC, Yang LY, Huang HJ, Chang WY, Lin H, Wu RC, Chen MY, Qiu JT, Huang KG, Chao A, Chang TC, Lai CH. Postoperative adjuvant dose-dense chemotherapy with bevacizumab and maintenance bevacizumab after neoadjuvant chemotherapy for advanced ovarian cancer: A phase II AGOG/TGOG trial. Eur J Obstet Gynecol Reprod Biol. 2021 Apr; 262:13-20.
2
Huang HJ, Tung HJ, Yang LY, Chao A, Tang YH, Chou HH, Chang WY, Wu RC, Huang CC, Lin CY, Liao MJ, Chen WC, Lin CT, Chen MY, Huang KG, Wang CJ, Chang TC, Lai CH. Role of human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia. Int J Cancer. 2021 Feb; 148(3):665-672.
3
Huang HJ, Yang LY, Tung HJ, Ku FC, Wu RC, Tang YH, Chang WY, Jung SM, Wang CC, Lin CT, Liu FY, Lin G, Chen MY, Chou HH, Chang TC, Chao A, Lai CH. Management and clinical outcomes of patients with recurrent/progressive ovarian clear cell carcinoma. J Formos Med Assoc. 2020 Apr; 119(4):793-804.
4
Fu HC, Chen JR, Chen MY, Hsu KF, Cheng WF, Chiang AJ, Ke YM, Chen YC, Chang YY, Huang CY, Kang CY, Kan YY, Hsiao SM, Yen MS. Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: A Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study. J Gynecol Oncol. 2018 Sep; 29(5):e76
